Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
82.25
-0.13 (-0.16%)
At close: Nov 2, 2026, 4:00 PM EST
81.50
-0.75 (-0.91%)
After-hours: Nov 2, 2026, 7:30 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.6 billion as of November 2, 2026. It is the 3,803rd most valuable company in the world and the 1,216th biggest in the United States. Its market cap has increased by 230.32% in one year.
Market Cap
4.60B
Enterprise Value
3.41B
1-Year Change
230.32%
Global Rank
Country Rank
#1,216 United States
Category
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.60B, an increase of 2,722.55%. That is a compound annual growth rate of 189.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 4.60B | 160.37% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 5.41B |
| Scholar Rock Holding | 5.23B |
| Cogent Biosciences | 5.16B |
| PTC Therapeutics | 5.09B |
| Erasca | 4.91B |
| CRISPR Therapeutics AG | 4.83B |
| Travere Therapeutics | 4.64B |
| Definium Therapeutics | 4.36B |